{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T21:09:59Z","timestamp":1781212199557,"version":"3.54.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,1,4]],"date-time":"2019-01-04T00:00:00Z","timestamp":1546560000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"JSPS KAKENHI","award":["Grant Number 26462036"],"award-info":[{"award-number":["Grant Number 26462036"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1245\/s10434-018-07132-7","type":"journal-article","created":{"date-parts":[[2019,1,4]],"date-time":"2019-01-04T11:47:52Z","timestamp":1546602472000},"page":"907-917","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Roles of Pin1 as a Key Molecule for EMT Induction by Activation of STAT3 and NF-\u03baB in Human Gallbladder Cancer"],"prefix":"10.1245","volume":"26","author":[{"given":"Shinichiro","family":"Nakada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Kuboki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Nojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyuki","family":"Yoshitomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsunori","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsukasa","family":"Takayashiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigetsugu","family":"Takano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaru","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Ohtsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,4]]},"reference":[{"key":"7132_CR1","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/jhbp.314","volume":"23","author":"S Ishihara","year":"2016","unstructured":"Ishihara S, Horiguchi A, Miyakawa S, Endo I, Miyazaki M, Takada T. Biliary tract cancer registry in Japan from 2008 to 2013. J Hepatobiliary Pancreat Sci. 2016;23:149\u201357.","journal-title":"J Hepatobiliary Pancreat Sci."},{"key":"7132_CR2","doi-asserted-by":"publisher","first-page":"4308","DOI":"10.1245\/s10434-014-3885-1","volume":"21","author":"R Higuchi","year":"2014","unstructured":"Higuchi R, Ota T, Araida T, et al. Surgical approaches to advanced gallbladder cancer: a 40-year single-institution study of prognostic factors and resectability. Ann Surg Oncol. 2014;21:4308\u201316.","journal-title":"Ann Surg Oncol."},{"key":"7132_CR3","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","volume":"362","author":"J Valle","year":"2010","unstructured":"Valle J, Wasan H, Palmer DH, et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med. 2010;362:1273\u201381.","journal-title":"N Engl J Med."},{"key":"7132_CR4","doi-asserted-by":"publisher","first-page":"S1093","DOI":"10.1245\/s10434-015-4768-9","volume":"22","author":"A Kato","year":"2015","unstructured":"Kato A, Shimizu H, Ohtsuka M, et al. Downsizing chemotherapy for initially unresectable locally advanced biliary tract cancer patients treated with gemcitabine plus cisplatin combination therapy followed by radical surgery. Ann Surg Oncol. 2015;22:S1093\u20139.","journal-title":"Ann Surg Oncol."},{"key":"7132_CR5","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1111\/j.1440-1746.2011.07048.x","volume":"27","author":"U Dutta","year":"2012","unstructured":"Dutta U. Gallbladder cancer: can newer insights improve the outcome? J Gastroenterol Hepatol. 2012;27:642\u201353.","journal-title":"J Gastroenterol Hepatol."},{"key":"7132_CR6","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/nrc822","volume":"2","author":"JP Thiery","year":"2002","unstructured":"Thiery JP. Epithelial\u2013mesenchymal transitions in tumour progression. Nat Rev Cancer. 2002;2:442\u201354.","journal-title":"Nat Rev Cancer."},{"key":"7132_CR7","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/nrc1075","volume":"3","author":"P Friedl","year":"2003","unstructured":"Friedl P, Wolf K. Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer. 2003;3:362\u201374.","journal-title":"Nat Rev Cancer."},{"key":"7132_CR8","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1002\/jcb.21695","volume":"104","author":"C Min","year":"2008","unstructured":"Min C, Eddy SF, Dherr DH, Sonenshein GS. NF-kappaB and epithelial to mesenchymal transition of cancer. J Cell Biochem. 2008;104:733\u201344.","journal-title":"J Cell Biochem."},{"key":"7132_CR9","first-page":"e28975","volume":"3","author":"MK Wendt","year":"2014","unstructured":"Wendt MK, Balanis N, Carlin CR, Schiemann WP. STAT3 and epithelial\u2013mesenchymal transitions in carcinomas. JAKSTAT. 2014;3:e28975.","journal-title":"JAKSTAT."},{"key":"7132_CR10","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nrc1275","volume":"4","author":"H Yu","year":"2004","unstructured":"Yu H, Jove R. The STATs of cancer: new molecular targets come of age. Nat Rev Cancer. 2004;4:97\u2013105.","journal-title":"Nat Rev Cancer."},{"key":"7132_CR11","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1126\/science.278.5345.1957","volume":"278","author":"MB Yaffe","year":"1997","unstructured":"Yaffe MB, Schutkowski M, Shen M, et al. Sequence-specific and phosphorylation-dependent proline isomerization: a potential mitotic regulatory mechanism. Science. 1997;278:1957\u201360.","journal-title":"Science."},{"key":"7132_CR12","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/S0962-8924(02)02253-5","volume":"12","author":"KP Lu","year":"2002","unstructured":"Lu KP, Liou YC, Zhou XZ. Pinning down proline-directed phosphorylation signaling. Trends Cell Biol. 2002;12:164\u201372.","journal-title":"Trends Cell Biol."},{"key":"7132_CR13","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/nrm2261","volume":"8","author":"KP Lu","year":"2007","unstructured":"Lu KP, Zhou XZ. The prolyl isomerase PIN1: a pivotal new twist in phosphorylation signalling and disease. Nat Rev Mol Cell Biol. 2007;8:904\u201316.","journal-title":"Nat Rev Mol Cell Biol."},{"key":"7132_CR14","doi-asserted-by":"publisher","first-page":"7656","DOI":"10.1038\/sj.onc.1210567","volume":"26","author":"C Lufei","year":"2007","unstructured":"Lufei C, Koh TH, Uchida T, Cao X. Pin1 is required for the Ser727 phosphorylation-dependent Stat3 activity. Oncogene. 2007;26:7656\u201364.","journal-title":"Oncogene."},{"key":"7132_CR15","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/j.1365-2443.2011.01575.x","volume":"17","author":"R Wakahara","year":"2012","unstructured":"Wakahara R, Kunimoto H, Tanino K, Kojima H, Shintaku H, Nakajima K. Phospho-Ser727 of STAT3 regulates STAT3 activity by enhancing dephosphorylation of phospho-Tyr705 largely through TC45. Genes Cells. 2012;17:132\u201345.","journal-title":"Genes Cells."},{"key":"7132_CR16","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1016\/S1097-2765(03)00490-8","volume":"12","author":"A Ryo","year":"2003","unstructured":"Ryo A, Suizu F, Yoshida Y, et al. Regulation of NF-kappaB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65\/RelA. Mol Cell. 2003;12:1413\u201326.","journal-title":"Mol Cell."},{"key":"7132_CR17","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1038\/bjc.2015.272","volume":"113","author":"K Shinoda","year":"2015","unstructured":"Shinoda K, Kuboki S, Shimizu H, et al. Pin1 facilitates NF-\u03baB activation and promotes tumour progression in human hepatocellular carcinoma. Br J Cancer. 2015;113:1323\u201331.","journal-title":"Br J Cancer."},{"key":"7132_CR18","first-page":"405","volume":"16","author":"F Deryckere","year":"1994","unstructured":"Deryckere F, Gannon F. A one-hour minipreparation technique for extraction of DNA-binding proteins from animal tissues. Biotechniques. 1994;16:405.","journal-title":"Biotechniques."},{"key":"7132_CR19","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1038\/nprot.2013.079","volume":"8","author":"M Reichert","year":"2013","unstructured":"Reichert M, Takano S, Heeg S, Bakir B, Botta GP, Rustgi AK. Isolation, culture and genetic manipulation of mouse pancreatic ductal cells. Nat Protoc. 2013;8:1354\u201365.","journal-title":"Nat Protoc"},{"key":"7132_CR20","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s10585-007-9058-x","volume":"24","author":"JH Egberts","year":"2007","unstructured":"Egberts JH, Schniewind B, Schafmayer C, et al. Establishment of a novel orthotopic xenograft model of human gallbladder carcinoma. Clin Exp Metastasis. 2007;24:141\u20138.","journal-title":"Clin Exp Metastasis."},{"key":"7132_CR21","doi-asserted-by":"publisher","first-page":"3735","DOI":"10.1038\/onc.2009.232","volume":"28","author":"GP Atkinson","year":"2009","unstructured":"Atkinson GP, Nozell SE, Harrison DK, Stonecypher MS, Chen D, Benveniste EN. The prolyl isomerase Pin1 regulates the NF-kappaB signaling pathway and interleukin-8 expression in glioblastoma. Oncogene. 2009;28:3735\u201345.","journal-title":"Oncogene."},{"key":"7132_CR22","doi-asserted-by":"publisher","first-page":"5953","DOI":"10.1021\/bi973162p","volume":"37","author":"L Henning","year":"1998","unstructured":"Henning L, Christner C, Kipping M, et al. Selective inactivation of parvulin-like peptidyl-prolyl cis\/trans isomerases by juglone. Biochemistry. 1998;37:5953\u201360.","journal-title":"Biochemistry."},{"key":"7132_CR23","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S1074-5521(02)00310-1","volume":"10","author":"T Uchida","year":"2003","unstructured":"Uchida T, Takamiya M, Takahashi M, et al. Pin1 and Par14 peptidyl prolyl isomerase inhibitors block cell proliferation. Chem Biol. 2003;10:15\u201324.","journal-title":"Chem Biol."},{"key":"7132_CR24","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1038\/nsmb1306","volume":"14","author":"F Mantovani","year":"2007","unstructured":"Mantovani F, Tocco F, Girardini J, et al. The prolyl isomerase Pin1 orchestrates p53 acetylation and dissociation from the apoptosis inhibitor iASPP. Nat Struct Mol Biol. 2007;14:912\u201320.","journal-title":"Nat Struct Mol Biol."},{"key":"7132_CR25","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.canlet.2011.09.004","volume":"314","author":"W Lin","year":"2012","unstructured":"Lin W, Jiang L, Chen Y, et al. Vascular endotherial growth factor-D promotes growth, lymphangiogenesis, and lymphatic metastasis in gallbladder cancer. Cancer Lett. 2012;314:127\u201336.","journal-title":"Cancer Lett."},{"key":"7132_CR26","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1245\/s10434-006-9191-9","volume":"14","author":"Y Mita","year":"2012","unstructured":"Mita Y, Ajiki T, Kamigaki T, et al. Antitumor effect of gemcitabine on orthotopically inoculated human gallbladder cancer cells in nude mice. Ann Surg Oncol. 2012;14:1374\u201380.","journal-title":"Ann Surg Oncol."},{"key":"7132_CR27","doi-asserted-by":"publisher","first-page":"3747","DOI":"10.7314\/APJCP.2014.15.8.3747","volume":"15","author":"Q Du","year":"2014","unstructured":"Du Q, Jiang L, Wang XQ, Pan W, She FF, Chen YL. Establishment of and comparison between orthotopic xenograft and subcutaneous xenograft models of gallbladder carcinoma. Asian Pac J Cancer Prev. 2014;15:3747\u201352.","journal-title":"Asian Pac J Cancer Prev."},{"key":"7132_CR28","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.jhep.2009.04.016","volume":"51","author":"S Kuboki","year":"2009","unstructured":"Kuboki S, Sakai N, Clarke C, Schuster R, Blanchard J, Edwards MN, Lentsch AB. The peptidyl-prolyl isomerase, Pin1, facilitates NF-kappaB binding in hepatocytes and protects against hepatic ischemia\/reperfusion injury. J Hepatol. 2009;51:296\u2013306.","journal-title":"J Hepatol."},{"key":"7132_CR29","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/ncb1818","volume":"11","author":"TH Lee","year":"2009","unstructured":"Lee TH, Tun-Kyi A, Shi R, et al. Essential role of Pin1 in the regulation of TRF1 stability and telomere maintenance. Nat Cell Biol. 2009;11:97\u2013105.","journal-title":"Nat Cell Biol."},{"key":"7132_CR30","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1073\/pnas.032404099","volume":"99","author":"YC Liou","year":"2002","unstructured":"Liou YC, Ryo A, Huang HK, et al. Loss of Pin1 function in the mouse causes phenotypes resembling cyclin D1-null phenotypes. Proc Natl Acad Sci USA. 2002;99:1335\u201340.","journal-title":"Proc Natl Acad Sci U S A."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-018-07132-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-018-07132-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-018-07132-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,3]],"date-time":"2020-01-03T19:04:07Z","timestamp":1578078247000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-018-07132-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,4]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["7132"],"URL":"https:\/\/doi.org\/10.1245\/s10434-018-07132-7","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,4]]},"assertion":[{"value":"25 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2019","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"There are no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}